Nigeria's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $0.90 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by collaborations between private and government agencies and improvement in overall healthcare infrastructure. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & Fujifilm.
Nigeria's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $0.90 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. It has one of the world's fastest increasing populations, with 5.5 live births per woman and a yearly population increase of 3.2 percent, and is projected to have reached 400 Mn individuals by 2050. According to the most recent WHO statistics, Coronary Heart Disease Deaths in Nigeria reached 61,374 in 2020, accounting for 4.14% of total fatalities.
Some examples of AI in Diagnostics include using CT images to detect cancer or cerebrovascular disease, using ECGs and cardiac MRI images to evaluate the probability of cardiac arrest or other heart disorders, categorizing skin conditions in skin images, and detecting diabetic retinopathy signs in eye images. In recent years, numerous firms have developed in the nation that is attempting to develop and execute AI-powered diagnostics. Several of these firms are creating smartphone apps to detect and cure various medical ailments. The collaboration between “The Institute of Human Virology in Nigeria” (IHVN) Fujifilm and Qure.ai allowed IHVN, which is financed by USAID, to install ultra-portable X-ray scanners coupled with AI for active case detection in Nigerian rural areas.
Market Growth Drivers
In collaboration with the Federal Ministry of Health (MoH), the Nigerian Sovereign Investment Authority (NSIA) has negotiated a series of contracts to upgrade and extend healthcare services through private-sector engagement. The agreements aim to increase the ability of specialty hospitals and diagnostic facilities to deliver enhanced medical treatment. Additionally, the increasing prevalence of chronic diseases, the increased need for more precise and effective diagnostic solutions, and the availability of cutting-edge information technology are expected to drive market expansion.
Market Restraints
Despite having more economic resources, the national budget allocation for health is 5% which is typically less than the WHO guideline of 15% and less than several Sub-Saharan African nations. Presently, less than 5% of the country is registered in the NHIS, and an approximated 120 Mn Nigerians lack health insurance coverage. One of the most significant barriers to AI diagnostics adoption in Nigeria is a lack of suitable infrastructure. Several portions of the nation continue to lack stable electrical and internet connectivity, both of which are required for AI diagnostics to work successfully. Another difficulty is a scarcity of experienced individuals in the field of AI diagnostics in Nigeria due to the high cost of training and restricted access to specialized education programs. Also, regulatory and legal issues must be addressed before AI diagnoses may be widely used in Nigeria.
Key Players
August 2022, The Institute of Human Virology in Nigeria (IHVN) has announced a collaboration with Fujifilm and Qure.ai, a worldwide supplier of AI-enabled medical imaging solutions, to leverage innovative technology to assist enhance tuberculosis (TB) screening outreach in Nigeria.
The National Agency for Food and Drug Administration and Control (NAFDAC), the National Drug Law Enforcement Agency (NDLEA), and the Federal Ministry of Health are the regulatory bodies in Nigeria with authority over medical devices. NAFDAC regulates the regulatory framework for the authorization of medical devices, as well as the process of product innovation, testing, and marketing.
The National Health Insurance Plan governs the national healthcare system in Nigeria (NHIS or the Scheme). Financial support to the Scheme is voluntary/optional, and all contributions must be made to the Health Maintenance Organization (HMO). The method of funding or contribution to the Scheme is determined by the program in which the enrolee has enrolled. The Scheme offers three programs: Formal Sector Health Insurance Programme, Informal Sector Health Insurance Programme, and Vulnerable Group Health Insurance Programme.
1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
The collaborations between private and government agencies and improvement in overall healthcare infrastructure are the major drivers of Artificial Intelligence (AI) in the diagnostics market in Nigeria.
IBM Watson Health, Siemens Healthineers, Fujifilm, Philips Healthcare, GE Healthcare, Google Health, AliveCor, Inc, Lunit Inc.& Qure.ai are the major players in the Artificial Intelligence (AI) In the diagnostics market in Nigeria.
Artificial Intelligence (AI) in the diagnostics market in Nigeria is segmented by component and by diagnosis.